A detailed history of Pettee Investors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Pettee Investors, Inc. holds 10,010 shares of ABBV stock, worth $2.02 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares
10,010
Previous 10,265 2.48%
Holding current value
$2.02 Million
Previous $1.76 Million 12.27%
% of portfolio
0.99%
Previous 0.88%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $41,779 - $50,829
-255 Reduced 2.48%
10,010 $1.98 Million
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $3.65 Million - $4.26 Million
-23,550 Reduced 69.64%
10,265 $1.76 Million
Q4 2023

Feb 07, 2024

SELL
$137.6 - $154.97 $67,011 - $75,470
-487 Reduced 1.42%
33,815 $5.24 Million
Q3 2023

Oct 20, 2023

SELL
$133.59 - $154.65 $44,084 - $51,034
-330 Reduced 0.95%
34,302 $5.11 Million
Q1 2023

May 05, 2023

SELL
$144.61 - $166.54 $11,568 - $13,323
-80 Reduced 0.23%
34,632 $5.52 Million
Q4 2022

Jan 25, 2023

BUY
$138.31 - $165.87 $38,035 - $45,614
275 Added 0.8%
34,712 $5.61 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $2,903 - $3,602
22 Added 0.06%
34,437 $5.58 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $99,372 - $125,735
925 Added 2.76%
34,415 $4.66 Million
Q2 2021

Aug 02, 2021

SELL
$105.21 - $117.21 $51,237 - $57,081
-487 Reduced 1.43%
33,490 $3.77 Million
Q1 2021

May 03, 2021

BUY
$102.3 - $112.62 $10,230 - $11,262
100 Added 0.3%
33,977 $3.68 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $61,574 - $83,132
765 Added 2.31%
33,877 $3.63 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $24,312 - $28,534
283 Added 0.86%
33,112 $2.9 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $51,606 - $60,738
669 Added 2.08%
32,829 $2.65 Million
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $2.25 Million - $2.87 Million
32,160
32,160 $2.86 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pettee Investors, Inc. Portfolio

Follow Pettee Investors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettee Investors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pettee Investors, Inc. with notifications on news.